What a weird, incongruous time. To be at one of the lowest points in your career while receiving one of your country’s ...
Your daily briefing on what’s going on with Mizzou athletics, including full TV listings.
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...
BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous autoinjector (SC-AI) as a weekly starting ...